Adeoye Olukotun

Neusentis is a biopharmaceutical company, which is focused on the discovery, development and commercialization of novel orally-administered small molecule drugs that modulate ion channel targets. The company has developed an integrated technology platform that allows for the efficient discovery of drug leads. The firm is conducting research and development activities in a number of disease areas, including epilepsy, pain and inflammation. Icagen has two clinical stage programs in epilepsy and pain. The company was formerly known as Icagen, Inc. It was founded by Andre L. Lamotte and P. Kay Wagoner on November 23, 1992 and is headquartered in Durham, NC.

SemBioSys Genetics, Inc. operates as a plant-based technology development company, which engages in the manufacturing technology platforms to develop, manufacture and commercialize healthy living, animal health and pharmaceutical products. It offers proteins, functional food and nutritional products. The company was founded by Maurice Moloney on April 25, 1994 and is headquartered in Calgary, Canada.

MDS Nordion, Inc. use to export medical isotopes, radio therapeutics and related technologies. Its products and services were used in hospitals, clinics, large medical supply companies, biotechnology, pharmaceutical companies, food processors and manufacturers. The company was founded in 1946 and was headquartered in Ottawa, Canada.

BioMedical Systems Corp. provides centralized diagnostic services to pharmaceutical and medical industries. It offers cardiac modalities, including digital 12-lead electrocardiogram (ECG), TQT/intensive studies, Holter monitoring, ambulatory blood pressure monitoring, and ECG stress testing. The firm also centralizes pulmonary function testing in pharmaceutical and medical device clinical trials for the modalities, including spirometry, peak flow with eDiary, challenge testing, pulse oximetry, nitric oxide, and DLco/lung volumes. The company was founded by W. Raymond Barrett in 1975 and is headquartered in St. Louis, MO.

D&R Greenway Land Trust is a non-profit organization which works to preserve and protect a permanent network of natural lands and open spaces in central New Jersey. The company was founded by Jim Amon, Rosemary Blair, Dennis Davidson, Sam Hamill, and Bob Johnston in 1989 and is headquartered in Princeton, NJ.

Abcentra, Inc. is an American clinical-stage biopharmaceutical company that specializes in developing novel antibody therapies for inflammatory diseases, with a particular focus on cardiovascular disease. The private company's patented technology allows for the targeting of oxidized lipoproteins and associated inflammatory responses. Abcentra's pipeline focuses on patient populations with high-risk of cardiometabolic complications that are exacerbated by chronic inflammation, including patients with inflammatory diseases and patients with residual inflammation. The company's lead compound, orticumab, is a novel monoclonal antibody that blocks inflammation from oxidized low-density lipoprotein and is slated to begin a phase 2 study later this year. Kevin B. Bacon has been the CEO of the company since 2020.

Diadexus, Inc. engages in the research, development, and commercialization of pharmaceutical products. Its portfolio intends to treat cardiovascular diseases. The company was founded on November 27, 1995 and is headquartered in South San Francisco, CA.

Electrophysiology Research Foundation operates as a charitable non-profit organization devoted solely to research and education in cardiac electrophysiology. It engages in the conducting research studies in the field of cardiac pharmacology, cardiac lectrophysiology, arrhythmia ablation, implantable pacemakers, and implantable cardioverter-defibrillators. The firm conducts and coordinates multicenter clinical trials, and basic research in cardiac electrophysiology and cardiac pacing. The company was founded by Sanjeev Saksena on August 2, 1982 and is headquartered in Warren, NJ.

Epigen Pharmaceuticals, Inc. develops cardiac reperfusion therapies. The private company is based in Princeton.

Genesis Unicorn Capital Corp. is a blank check company. It was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded on February 23, 2021 and is headquartered in Princeton, NJ.